Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients

The American Journal of Medicine
J R GraybillB L Moskovitz

Abstract

Oropharyngeal candidasis (thrush) is the most common opportunistic infection in individuals who are positive for the human immunodeficiency virus (HIV) and those who have progressed to AIDS. Itraconazole has a broad in vitro spectrum of activity, including a wide variety of Candida species. Our study determined the relative efficacy of a new oral solution formulation of itraconazole and fluconazole tablets in the treatment of oropharyngeal candidiasis. This was a prospective randomized, third-party-blind, multicenter trial conducted at 12 centers in the United States. One hundred seventy-nine HIV-positive patients with mycologically documented oropharyngeal candidiasis were treated with itraconazole oral solution 200 mg/ day for 7 or 14 days, or fluconazole tablets 100 mg/day for 14 days. Severity of disease was scored clinically before treatment and at clinical evaluations on days 3, 7, 14, 21, 35, and 42. Semi-quantitative cultures of mouth washings were also obtained on these days. Both 14-day and 7-day regimens of itraconazole oral solution were equivalent to fluconazole for most efficacy parameters. The clinical response rate was 97% after 14 days of itraconazole and 87% after 14 days of fluconazole. Itraconazole oral solu...Continue Reading

References

Feb 1, 1992·Antimicrobial Agents and Chemotherapy·J S HostetlerD A Stevens
Mar 1, 1990·Reviews of Infectious Diseases·R J Hay
Feb 1, 1984·Archives of Internal Medicine·N J OwensR Quintiliani
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexM A Pfaller
Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A GoffR J Fass
Oct 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S L NewmanK Vigilante
Oct 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A White, M B Goetz
Feb 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S ReddingM Pfaller

❮ Previous
Next ❯

Citations

Jul 31, 2007·Future Microbiology·Jose A Vazquez
May 20, 1999·Pharmacotherapy·D A Stevens
Oct 17, 2012·Clinics in Dermatology·David A Stevens
Jan 8, 2016·Infectious Disease Clinics of North America·Jeniel E Nett, David R Andes
Mar 24, 2007·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Lorena BaccagliniDouglas E Peterson
Jun 2, 2000·Seminars in Cutaneous Medicine and Surgery·R A Johnson
Feb 7, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M C ArendrupUNKNOWN Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
Jan 4, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A J UllmannUNKNOWN ESCMID Fungal Infection Study Group
Jan 4, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O LortholaryUNKNOWN ESCMID Fungal Infection Study Group
Jun 26, 2001·Journal of Clinical Pharmacy and Therapeutics·L WillemsK de Beule
Dec 10, 1999·The Journal of Antimicrobial Chemotherapy·M V Martin
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Oct 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Omar J M HamzaAndré J A M van der Ven
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Nov 23, 2017·Osong Public Health and Research Perspectives·Jae-Sug LeeJeong-Min Seong
May 18, 2016·The American Journal of Hospice & Palliative Care·Ruth LagmanLisa Rybicki
Nov 11, 1999·AIDS Research and Human Retroviruses·W G PowderlyJ R Perfect
Oct 16, 2004·Expert Review of Anti-infective Therapy·Raymond Cha, Jack D Sobel
Mar 21, 2007·Archives of Pharmacal Research·Yun-Seok RheeEun-Seok Park
Feb 24, 2001·Drugs·J F Meis, P E Verweij
Feb 24, 2001·Drugs·K De Beule, J Van Gestel
Jun 16, 2001·The American Journal of Hospice & Palliative Care·M P Sweeney, J Bagg
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Elizabeth D PienaarHaly Holmes
Nov 18, 1998·The Journal of International Medical Research·B VandercamO Armignacco
Sep 12, 2000·The Annals of Pharmacotherapy·J A Sabo, S M Abdel-Rahman
Mar 14, 2020·The Journal of Prosthetic Dentistry·Jiaying FangZan Ding
Jan 9, 1999·Clinical Microbiology Reviews·D J SheehanC M Sibley
Sep 24, 2015·Microbiology Spectrum·Jeniel E Nett, David R Andes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

JAMA : the Journal of the American Medical Association
P K HonigL R Cantilena
The Journal of Infectious Diseases
W T HughesH Tufenkeji
Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology
B DupontT Sirisanthana
© 2022 Meta ULC. All rights reserved